The final decision on cell fate, survival versus cell death, relies on complex 17 
When encountering a stress condition, cells have two options, either to cope with 47 it, which requires an adaptive response, or to give up and die, which involves the 48 initiation of an active and programmed cell death process. Cells are in fact well 49 equipped to sense the extent of stress and this allows them to decide whether 50 they should try to restore homeostasis or whether they should commit suicide 51 because stress is evaluated as too extensive and potentially deleterious. Various 52 switch mechanisms can be used by cells to evaluate stress and insults to either 53 3 promote cell survival or apoptosis. We will focus here on a newly described 54 physiologic stress-sensing cellular system based on the differential cleavage of a 55 specific caspase-3 substrate. 56 57 Caspase-3, from reaper to friendly protease 58
At the end of the nineties, a consensus emerged that apoptosis (Box1) was 59 carried on by the executioner members of the caspase family (Box1) (caspase-3, 60 -6, and -7) [5] [6] [7] [8] . Caspase-3 has been considered as the central executioner 61 protease due to its high catalytic turnover and greediness to cleave substrates 62 [9] . Gene targeting in mice has revealed a certain level of redundancy in the 63 function of executioner caspases in apoptosis induction [10] , and more 64 importantly that these executioner caspases fulfill other non-apoptotic functions 65 as well [11] . 66
Historically however, non-apoptotic functions of pro-apoptotic caspases were 67 first discovered for caspase-8, an initiator caspase. It was shown in 1998 that 68 mice lacking caspase-8 were embryonic lethal [12] . This lethality was later 69
shown to result from degeneration of the vasculature of the yolk sac [13] . This 70 suggested that caspase-8 is required for the proper development and/or the 71 maintenance of vascular structures in the early embryo, which is most certainly 72 distinct from its ability to mediate apoptosis via the extrinsic cell death pathway. 73 Also in 1998, it was shown that cell expressing CrmA, a caspase-8 inhibitor, were 74 paradoxically sensitized to necrotic cell death [14] caspase-3 appears to cleave most substrates more efficiently than other caspases 95 [29] . It is conceivable that the high K m value of caspase-3 for some of its 96 substrates is related to its non-apoptotic functions while apoptosis may imply 97 the less effective substrates. In other words, low activation levels of caspase-3, 98 leading to restricted cleavage of high affinity substrates, would allow survival 99 while higher levels of caspase-3 activation would result in the cleavage of a much 100 wider spectrum of substrates, including low affinity ones, ultimately leading to 101 the induction of apoptosis. members allow cells to cope with stress to a certain limit if they are expressed at 118 sufficiently high levels either by activating NF-kB, preventing RIPK1 from 119 becoming a pro-death molecule or by keeping caspase-3 activity in check. 120
Another possibility that can explain why activation of caspase-3 does not lead to 121 apoptosis in all cases is that caspase-3 itself, when activated at low levels, turns 122 on an anti-apoptotic response that acts as a negative feedback loop preventing 123 further caspase-3 activation (i.e. an amplification of caspase-3 activity). A recent 124 study [38] reduces the apoptotic response, this does not mean necessarily that the death 148 response is lowered. For example, UV-B-induced apoptosis is decreased in the 149 epidermis of caspase-3 KO mice but the overall death response is not, as in the 150 absence of apoptosis induction cell death proceeds in caspase-independent cell 151 death with necrotic morphology [38] . 152 7
In some cases, caspase-7 can compensate, at least partially by enhanced 153 expression levels in C57Bl6 strains for the lack of caspase-3 and allow apoptosis 154 to proceed [10] . Doxorubicin is an efficient anti-cancer drug that is currently 155 used against various tumors. However, this drug also induces serious cardiac 156 side effects. Cardiomyocytes are indeed rather sensitive to doxorubicin and 157 readily undergo apoptosis when exposed to the drug. Unexpectedly, caspase-3 158 knock-out mice experience even more cardiomyocyte apoptosis than wild-type 159 mice when treated with doxorubicin, leading to increased mortality [38] . This 160 suggests that the apoptotic role of caspase-3 is redundant while its prosurvival 161 role in stressed tissues and organs is not. Consequently, the second site is not used when caspase-3 is mildly activated [52] 
